Font Size: a A A
Keyword [doxorubicin-induced cardiotoxicity]
Result: 21 - 38 | Page: 2 of 2
21. Loss Of Rubicon Ameliorates Doxorubicin-induced Cardiotoxicity
22. MicroRNA-31-5p Attenuates Doxorubicin-Induced Cardiotoxicity Via Quaking And Circular RNA Pan3
23. Mechanisms and management of doxorubicin-induced cardiotoxicity
24. Role of cytochrome P450 enzymes in the pathogenesis of cardiac hypertrophy and doxorubicin-induced cardiotoxicity
25. The Role And Mechanism Of CREG In Doxorubicin Induced Cardiotoxicity
26. DiOHF Protects Against And Reverses Doxorubicin-induced Cardiotoxicity By The ERK1/2 Signaling Pathway
27. UVRAG Deficiency Exacerbates Doxorubicin-induced Cardiotoxicity
28. CACNA1H Is Involved In Doxorubicin Induced Cardiotoxicity By Regulating Endoplasmic Reticulum Stress-related Pathways
29. Prevention Of Noninvasive Vagal Nerve Stimulation Against Doxorubicin-induced Cardiotoxicity And The Underlying Mechanism
30. The Study On The Effect And Mechanism Of Doxorubicin-induced Cardiotoxicity Based On Transcriptomics And Metabolomics Analysis In Vitro
31. Effects Of Elabela On Doxorubicin-induced Cardiotoxicity
32. The Role Of Acot1 In Doxorubicin-induced Cardiotoxicity
33. Interleukin-9 Aggravates Doxorubicin-Induced Cardiotoxicity By Promoting Inflammation And Apoptosis In Mice
34. Research On SGLT2 Inhibitor Alleviating Doxorubicin Induced Cardiotoxicity
35. Preparation Of Panax Ginseng Protein And Its Protective Mechanism Against Doxorubicin Induced Cardiotoxicity
36. Mechanisms Of Doxorubicin-induced Cardiotoxicity Mediated By Transcription Factor E2F1
37. Dissecting Chemical Composition And Cardioprotective Effects Of Fuzhengkangfu Decoction Against Doxorubicin-Induced Cardiotoxicity Approaches
38. Research On The Role And Mechanism Of MicroRNA-146a In Doxorubicin-induced Cardiotoxicity
  <<First  <Prev  Next>  Last>>  Jump to